xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05975398</url>
    </required_header>
    <id_info>
      <org_study_id>KY2019-096-02-1</org_study_id>
      <nct_id>NCT05975398</nct_id>
    </id_info>
    <brief_title>China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）</brief_title>
    <official_title>China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Beijing Tiantan Hospital</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
      <collaborator>
        <agency>Beijing Chao Yang Hospital</agency>
        <agency_class>Other</agency_class>
      </collaborator>
      <collaborator>
        <agency>Beijing Shuyi Hospital</agency>
        <agency_class>Other</agency_class>
      </collaborator>
      <collaborator>
        <agency>Beijing Anzhen Hospital</agency>
        <agency_class>Other</agency_class>
      </collaborator>
      <collaborator>
        <agency>Guangzhou Red Cross Hospital</agency>
        <agency_class>Other</agency_class>
      </collaborator>
      <collaborator>
        <agency>Beijing Pinggu District Hospital</agency>
        <agency_class>Other</agency_class>
      </collaborator>
    </sponsors>
    <source>Beijing Tiantan Hospital</source>
    <oversight_info>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        Background: Despite the capability of emergency surgery to reduce the mortality of severe&#xD;
        spontaneous intracranial hemorrhage (SSICH) patients, the effect and safety of surgical&#xD;
        treatment for severe spontaneous intracranial hemorrhage (SSICH) patients receiving long-term&#xD;
        oral antiplatelet treatment (LOAPT) remains unclear. In consideration of this, the cohort&#xD;
        study is aimed at figuring out the effect and safety of emergency surgery for SSICH patients&#xD;
        on LOAPT.&#xD;
  &#xD;
        Methods: As a multicenter and prospective cohort study, it will be conducted across 7&#xD;
        representative clinical centers. Starting in September 2019, the observation is scheduled to&#xD;
        be completed by December 2022, with a total of 450 SSICH patients recruited. The information&#xD;
        on clinical, radiological, and laboratory practices will be recorded objectively. All of the&#xD;
        patients will be monitored until death or 6 months after the occurrence of primary&#xD;
        hemorrhage.&#xD;
  &#xD;
        Study Design: In this study, two comparative cohorts and an observational cohort will be set&#xD;
        up. The primary outcome is the effect of emergency surgery, which is subject to assessment&#xD;
        using the total mortality and comparison in the survival rate of SSICH patients on LOAPT&#xD;
        between surgical treatment and conservative treatment. The second outcome is the safety of&#xD;
        surgery, with the postoperative hemorrhagic complication which is compared between the&#xD;
        operated SSICH patients on and not on LOAPT. Based on the observation of the characteristics&#xD;
        and outcome of SSICH patients on LOAPT, the ischemic events after discontinuing LOAPT will be&#xD;
        further addressed, and the coagulation function assessment system for operated SSICH patients&#xD;
        on LOAPT will be established.&#xD;
  &#xD;
        Objective: In this study, investigators will estimate the effect and safety of emergency&#xD;
        surgery for SSICH patients on LOAPT, which will provide an evidence for management in the&#xD;
        future.&#xD;
      </textblock>
    </brief_summary>
    <overall_status>Completed</overall_status>
    <start_date type="Actual">July 10, 2019</start_date>
    <completion_date type="Actual">November 30, 2022</completion_date>
    <primary_completion_date type="Actual">May 31, 2022</primary_completion_date>
    <study_type>Observational [Patient Registry]</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <observational_model>Cohort</observational_model>
      <time_perspective>Prospective</time_perspective>
    </study_design_info>
    <target_duration>6 Months</target_duration>
    <primary_outcome>
      <measure>Total mortality</measure>
      <time_frame>From admission to 6 months after the occurrence primary hemorrhage</time_frame>
    </primary_outcome>
    <secondary_outcome>
      <measure>Postoperative intracranial bleeding</measure>
      <time_frame>Within one week after surgery</time_frame>
    </secondary_outcome>
    <enrollment type="Actual">450</enrollment>
    <condition>Severe Spontaneous Intracranial Hemorrhage</condition>
    <condition>Long-term Antiplatelet Treatment</condition>
    <condition>Emergency Surgery</condition>
    <condition>Complications</condition>
    <intervention>
      <intervention_type>Procedure</intervention_type>
      <intervention_name>Emergency neurosurgery</intervention_name>
      <description>Surgical evacuation for intracerebral hemorrhage</description>
    </intervention>
    <intervention>
      <intervention_type>Procedure</intervention_type>
      <intervention_name>Conservative treatment</intervention_name>
      <description>Standard treatment for intracerebral hemorrhage</description>
    </intervention>
    <eligibility>
      <study_pop>
        <textblock>
          All severe spontaneous intracerebral hemorrhage (SSICH) patients except those not on&#xD;
          long-term oral antiplatelet treatment (LOAPT) receiving conservative treatment.&#xD;
        </textblock>
      </study_pop>
      <sampling_method>Non-Probability Sample</sampling_method>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  (1) 18-75 years old;&#xD;
  &#xD;
            -  (2) non-traumatic intracerebral hemorrhage;&#xD;
  &#xD;
            -  (3) severe intracerebral hemorrhage, which was defined as patients with supratentorial&#xD;
               bleeding volume &gt; 30 ml, infratentorial bleeding volume &gt; 10 ml, midline shift &gt; 1 cm,&#xD;
               or large intraventricular hematoma;&#xD;
  &#xD;
            -  (4) Glasgow coma score (GCS) &lt; 13;&#xD;
  &#xD;
            -  (5) family members agree to provide an informed written consent.&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  (1) patients had cerebrovascular diseases, e.g., intracranial aneurysm or vascular&#xD;
               malformation, and intracranial tumors, which were associated with hemorrhage;&#xD;
  &#xD;
            -  (2) hemorrhagic transformation of cerebral infarction;&#xD;
  &#xD;
            -  (3) hemorrhage caused by venous thrombosis;&#xD;
  &#xD;
            -  (4) patients with severe coagulation disorder, e.g., hemophilia;&#xD;
  &#xD;
            -  (5) patients with coagulation dysfunction caused by malignant tumor, hepatic&#xD;
               insufficiency, renal dysfunction, thrombocytopenia, coagulation diseases, and so on;&#xD;
  &#xD;
            -  (6) patients receiving other anticoagulation medications (vitamin K antagonist and new&#xD;
               oral anticoagulants);&#xD;
  &#xD;
            -  (7) patients not on LOAPT who receive conservative treatment;&#xD;
  &#xD;
            -  (8) the patients who died before or on arriving at the hospital and within a short&#xD;
               period (6 h) after admission.&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>75 Years</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Shuo Wang</last_name>
      <role>Study Chair</role>
      <affiliation>Beijing Tiantan Hospital</affiliation>
    </overall_official>
    <location>
      <facility>
        <name>Capital Medical University Affiliated Beijing Tiantan Hospital</name>
        <address>
          <city>Beijing</city>
          <state>Beijing</state>
          <country>China</country>
        </address>
      </facility>
    </location>
    <location_countries>
      <country>China</country>
    </location_countries>
    <results_reference>
      <citation>Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6. Erratum In: Lancet. 2019 Feb 2;393(10170):406.</citation>
      <PMID>30319113</PMID>
    </results_reference>
    <results_reference>
      <citation>Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28.</citation>
      <PMID>26022637</PMID>
    </results_reference>
    <results_reference>
      <citation>Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010 Sep;41(9):2108-29. doi: 10.1161/STR.0b013e3181ec611b. Epub 2010 Jul 22.</citation>
      <PMID>20651276</PMID>
    </results_reference>
    <results_reference>
      <citation>Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM; STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013 Aug 3;382(9890):397-408. doi: 10.1016/S0140-6736(13)60986-1. Epub 2013 May 29. Erratum In: Lancet. 2013 Aug 3;382(9890):396. Lancet. 2021 Sep 18;398(10305):1042.</citation>
      <PMID>23726393</PMID>
    </results_reference>
    <results_reference>
      <citation>Goyal N, Tsivgoulis G, Malhotra K, Katsanos AH, Pandhi A, Alsherbini KA, Chang JJ, Hoit D, Alexandrov AV, Elijovich L, Fiorella D, Nickele C, Arthur AS. Minimally invasive endoscopic hematoma evacuation vs best medical management for spontaneous basal-ganglia intracerebral hemorrhage. J Neurointerv Surg. 2019 Jun;11(6):579-583. doi: 10.1136/neurintsurg-2018-014447. Epub 2019 Jan 7.</citation>
      <PMID>30617144</PMID>
    </results_reference>
    <results_reference>
      <citation>Wang WZ, Jiang B, Liu HM, Li D, Lu CZ, Zhao YD, Sander JW. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke. 2009 Feb;4(1):11-6. doi: 10.1111/j.1747-4949.2009.00239.x.</citation>
      <PMID>19236490</PMID>
    </results_reference>
    <results_reference>
      <citation>Xia Z, Wu X, Li J, Liu Z, Chen F, Zhang L, Zhang H, Wan X, Cheng Q. Minimally Invasive Surgery is Superior to Conventional Craniotomy in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. World Neurosurg. 2018 Jul;115:266-273. doi: 10.1016/j.wneu.2018.04.181. Epub 2018 May 3.</citation>
      <PMID>29730105</PMID>
    </results_reference>
    <results_reference>
      <citation>Lovelock CE, Molyneux AJ, Rothwell PM; Oxford Vascular Study. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007 Jun;6(6):487-93. doi: 10.1016/S1474-4422(07)70107-2. Erratum In: Lancet Neurol. 2007 Sep;6(9):757.</citation>
      <PMID>17509483</PMID>
    </results_reference>
    <results_reference>
      <citation>Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013 May 30;368(22):2113-24. doi: 10.1056/NEJMra1206531. No abstract available.</citation>
      <PMID>23718166</PMID>
    </results_reference>
    <results_reference>
      <citation>Krittalak K, Sawanyawisuth K, Tiamkao S. Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage. Intern Med J. 2011 Oct;41(10):750-4. doi: 10.1111/j.1445-5994.2011.02579.x.</citation>
      <PMID>22435901</PMID>
    </results_reference>
    <results_reference>
      <citation>Cahill RA, McGreal GT, Crowe BH, Ryan DA, Manning BJ, Cahill MR, Redmond HP. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg. 2005 Apr;200(4):564-73; quiz A59-61. doi: 10.1016/j.jamcollsurg.2004.11.002.</citation>
      <PMID>15804471</PMID>
    </results_reference>
    <results_reference>
      <citation>Korinth MC. Low-dose aspirin before intracranial surgery--results of a survey among neurosurgeons in Germany. Acta Neurochir (Wien). 2006 Nov;148(11):1189-96; discussion 1196. doi: 10.1007/s00701-006-0868-4. Epub 2006 Sep 21.</citation>
      <PMID>16969624</PMID>
    </results_reference>
    <results_reference>
      <citation>de Miguel-Diez J, Gomez Martinez A, Montero Martinez C. Perioperative and Periprocedural Management of Antithrombotic Therapy. Arch Bronconeumol (Engl Ed). 2019 May;55(5):229-230. doi: 10.1016/j.arbres.2018.07.019. Epub 2018 Sep 5. No abstract available. English, Spanish.</citation>
      <PMID>30193947</PMID>
    </results_reference>
    <results_reference>
      <citation>Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):299S-339S. doi: 10.1378/chest.08-0675.</citation>
      <PMID>18574269</PMID>
    </results_reference>
    <results_reference>
      <citation>Douketis JD, Bakhsh E. Perioperative management of antithrombotic therapy. Pol Arch Med Wewn. 2008 Apr;118(4):201-8.</citation>
      <PMID>18575419</PMID>
    </results_reference>
    <results_reference>
      <citation>Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery. 1998 Apr;42(4):769-73. doi: 10.1097/00006123-199804000-00053.</citation>
      <PMID>9574641</PMID>
    </results_reference>
    <results_reference>
      <citation>Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005 Apr;27(2):81-90. doi: 10.1111/j.1365-2257.2005.00681.x.</citation>
      <PMID>15784122</PMID>
    </results_reference>
    <results_reference>
      <citation>Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T, Pezold M, Lawrence J, Biffl WL, Cothren CC, Johnson JL. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009 Oct;146(4):764-72; discussion 772-4. doi: 10.1016/j.surg.2009.06.054.</citation>
      <PMID>19789037</PMID>
    </results_reference>
    <results_reference>
      <citation>Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14.</citation>
      <PMID>19443791</PMID>
    </results_reference>
    <results_reference>
      <citation>Prasad K, Mendelow AD, Gregson B. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000200. doi: 10.1002/14651858.CD000200.pub2.</citation>
      <PMID>18843607</PMID>
    </results_reference>
    <results_reference>
      <citation>Li Y, Yang R, Li Z, Yang Y, Tian B, Zhang X, Wang B, Lu D, Guo S, Man M, Yang Y, Luo T, Gao G, Li L. Surgical Evacuation of Spontaneous Supratentorial Lobar Intracerebral Hemorrhage: Comparison of Safety and Efficacy of Stereotactic Aspiration, Endoscopic Surgery, and Craniotomy. World Neurosurg. 2017 Sep;105:332-340. doi: 10.1016/j.wneu.2017.05.134. Epub 2017 May 31.</citation>
      <PMID>28578111</PMID>
    </results_reference>
    <results_reference>
      <citation>Yao Z, Ma L, You C, He M. Decompressive Craniectomy for Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis. World Neurosurg. 2018 Feb;110:121-128. doi: 10.1016/j.wneu.2017.10.167. Epub 2017 Nov 10.</citation>
      <PMID>29129764</PMID>
    </results_reference>
    <results_reference>
      <citation>Zheng J, Li H, Zhao HX, Guo R, Lin S, Dong W, Ma L, Fang Y, Tian M, Liu M, You C. Surgery for Patients With Spontaneous Deep Supratentorial Intracerebral Hemorrhage: A Retrospective Case-Control Study Using Propensity Score Matching. Medicine (Baltimore). 2016 Mar;95(11):e3024. doi: 10.1097/MD.0000000000003024.</citation>
      <PMID>26986116</PMID>
    </results_reference>
    <results_reference>
      <citation>Stein M, Misselwitz B, Hamann GF, Kolodziej M, Reinges MH, Uhl E. In-hospital mortality after pre-treatment with antiplatelet agents or oral anticoagulants and hematoma evacuation of intracerebral hematomas. J Clin Neurosci. 2016 Apr;26:42-5. doi: 10.1016/j.jocn.2015.05.069. Epub 2015 Dec 11.</citation>
      <PMID>26690758</PMID>
    </results_reference>
    <results_reference>
      <citation>Khoo KF, Lepas B. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Jan 7;82(1):95. doi: 10.1212/01.NEUROLOGY.0000437348.92583.18. No abstract available.</citation>
      <PMID>24379098</PMID>
    </results_reference>
    <results_reference>
      <citation>Holzmacher JL, Reynolds C, Patel M, Maluso P, Holland S, Gamsky N, Moore H, Acquista E, Carrick M, Amdur R, Hancock H, Metzler M, Dunn J, Sarani B. Platelet transfusion does not improve outcomes in patients with brain injury on antiplatelet therapy. Brain Inj. 2018;32(3):325-330. doi: 10.1080/02699052.2018.1425804. Epub 2018 Jan 17.</citation>
      <PMID>29341793</PMID>
    </results_reference>
    <results_reference>
      <citation>Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD; Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology. 2003 Sep;110(9):1784-8. doi: 10.1016/S0161-6420(03)00785-1. Erratum In: Ophthalmology. 2003 Dec;110(12):2309.</citation>
      <PMID>13129878</PMID>
    </results_reference>
    <verification_date>August 2023</verification_date>
    <study_first_submitted>July 18, 2023</study_first_submitted>
    <study_first_submitted_qc>August 2, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 3, 2023</study_first_posted>
    <last_update_submitted>August 2, 2023</last_update_submitted>
    <last_update_submitted_qc>August 2, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 3, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
      <investigator_full_name>Wang Shuo</investigator_full_name>
      <investigator_title>Director of Department of Cerebrovascular Neurosurgery</investigator_title>
    </responsible_party>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Cerebral Hemorrhage</mesh_term>
      <mesh_term>Intracranial Hemorrhages</mesh_term>
      <mesh_term>Emergencies</mesh_term>
      <mesh_term>Hemorrhage</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05975398
  org study id: KY2019-096-02-1
  nct id: NCT05975398
  lead sponsor: 
  collaborator: 
  collaborator: 
  collaborator: 
  collaborator: 
  collaborator: 
  is fda regulated drug: No
  is fda regulated device: No
  Background: Despite the capability of emergency surgery to reduce the mortality of severe
        spontaneous intracranial hemorrhage (SSICH) patients, the effect and safety of surgical
        treatment for severe spontaneous intracranial hemorrhage (SSICH) patients receiving long-term
        oral antiplatelet treatment (LOAPT) remains unclear. In consideration of this, the cohort
        study is aimed at figuring out the effect and safety of emergency surgery for SSICH patients
        on LOAPT.
  
        Methods: As a multicenter and prospective cohort study, it will be conducted across 7
        representative clinical centers. Starting in September 2019, the observation is scheduled to
        be completed by December 2022, with a total of 450 SSICH patients recruited. The information
        on clinical, radiological, and laboratory practices will be recorded objectively. All of the
        patients will be monitored until death or 6 months after the occurrence of primary
        hemorrhage.
  
        Study Design: In this study, two comparative cohorts and an observational cohort will be set
        up. The primary outcome is the effect of emergency surgery, which is subject to assessment
        using the total mortality and comparison in the survival rate of SSICH patients on LOAPT
        between surgical treatment and conservative treatment. The second outcome is the safety of
        surgery, with the postoperative hemorrhagic complication which is compared between the
        operated SSICH patients on and not on LOAPT. Based on the observation of the characteristics
        and outcome of SSICH patients on LOAPT, the ischemic events after discontinuing LOAPT will be
        further addressed, and the coagulation function assessment system for operated SSICH patients
        on LOAPT will be established.
  
        Objective: In this study, investigators will estimate the effect and safety of emergency
        surgery for SSICH patients on LOAPT, which will provide an evidence for management in the
        future.
  observational model: Cohort
  time perspective: Prospective
  measure: Total mortality
  time frame: From admission to 6 months after the occurrence primary hemorrhage
  measure: Postoperative intracranial bleeding
  time frame: Within one week after surgery
  intervention type: Procedure
  intervention name: Emergency neurosurgery
  description: Surgical evacuation for intracerebral hemorrhage
  intervention type: Procedure
  intervention name: Conservative treatment
  description: Standard treatment for intracerebral hemorrhage
  study pop: 
  sampling method: Non-Probability Sample
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: 75 Years
  healthy volunteers: No
  last name: Shuo Wang
  role: Study Chair
  affiliation: Beijing Tiantan Hospital
  facility: 
  country: China
  citation: Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6. Erratum In: Lancet. 2019 Feb 2;393(10170):406.
  PMID: 30319113
  citation: Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015 Jul;46(7):2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28.
  PMID: 26022637
  citation: Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010 Sep;41(9):2108-29. doi: 10.1161/STR.0b013e3181ec611b. Epub 2010 Jul 22.
  PMID: 20651276
  citation: Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM; STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013 Aug 3;382(9890):397-408. doi: 10.1016/S0140-6736(13)60986-1. Epub 2013 May 29. Erratum In: Lancet. 2013 Aug 3;382(9890):396. Lancet. 2021 Sep 18;398(10305):1042.
  PMID: 23726393
  citation: Goyal N, Tsivgoulis G, Malhotra K, Katsanos AH, Pandhi A, Alsherbini KA, Chang JJ, Hoit D, Alexandrov AV, Elijovich L, Fiorella D, Nickele C, Arthur AS. Minimally invasive endoscopic hematoma evacuation vs best medical management for spontaneous basal-ganglia intracerebral hemorrhage. J Neurointerv Surg. 2019 Jun;11(6):579-583. doi: 10.1136/neurintsurg-2018-014447. Epub 2019 Jan 7.
  PMID: 30617144
  citation: Wang WZ, Jiang B, Liu HM, Li D, Lu CZ, Zhao YD, Sander JW. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke. 2009 Feb;4(1):11-6. doi: 10.1111/j.1747-4949.2009.00239.x.
  PMID: 19236490
  citation: Xia Z, Wu X, Li J, Liu Z, Chen F, Zhang L, Zhang H, Wan X, Cheng Q. Minimally Invasive Surgery is Superior to Conventional Craniotomy in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. World Neurosurg. 2018 Jul;115:266-273. doi: 10.1016/j.wneu.2018.04.181. Epub 2018 May 3.
  PMID: 29730105
  citation: Lovelock CE, Molyneux AJ, Rothwell PM; Oxford Vascular Study. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007 Jun;6(6):487-93. doi: 10.1016/S1474-4422(07)70107-2. Erratum In: Lancet Neurol. 2007 Sep;6(9):757.
  PMID: 17509483
  citation: Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013 May 30;368(22):2113-24. doi: 10.1056/NEJMra1206531. No abstract available.
  PMID: 23718166
  citation: Krittalak K, Sawanyawisuth K, Tiamkao S. Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage. Intern Med J. 2011 Oct;41(10):750-4. doi: 10.1111/j.1445-5994.2011.02579.x.
  PMID: 22435901
  citation: Cahill RA, McGreal GT, Crowe BH, Ryan DA, Manning BJ, Cahill MR, Redmond HP. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg. 2005 Apr;200(4):564-73; quiz A59-61. doi: 10.1016/j.jamcollsurg.2004.11.002.
  PMID: 15804471
  citation: Korinth MC. Low-dose aspirin before intracranial surgery--results of a survey among neurosurgeons in Germany. Acta Neurochir (Wien). 2006 Nov;148(11):1189-96; discussion 1196. doi: 10.1007/s00701-006-0868-4. Epub 2006 Sep 21.
  PMID: 16969624
  citation: de Miguel-Diez J, Gomez Martinez A, Montero Martinez C. Perioperative and Periprocedural Management of Antithrombotic Therapy. Arch Bronconeumol (Engl Ed). 2019 May;55(5):229-230. doi: 10.1016/j.arbres.2018.07.019. Epub 2018 Sep 5. No abstract available. English, Spanish.
  PMID: 30193947
  citation: Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):299S-339S. doi: 10.1378/chest.08-0675.
  PMID: 18574269
  citation: Douketis JD, Bakhsh E. Perioperative management of antithrombotic therapy. Pol Arch Med Wewn. 2008 Apr;118(4):201-8.
  PMID: 18575419
  citation: Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery. 1998 Apr;42(4):769-73. doi: 10.1097/00006123-199804000-00053.
  PMID: 9574641
  citation: Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005 Apr;27(2):81-90. doi: 10.1111/j.1365-2257.2005.00681.x.
  PMID: 15784122
  citation: Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, Le T, Pezold M, Lawrence J, Biffl WL, Cothren CC, Johnson JL. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009 Oct;146(4):764-72; discussion 772-4. doi: 10.1016/j.surg.2009.06.054.
  PMID: 19789037
  citation: Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14.
  PMID: 19443791
  citation: Prasad K, Mendelow AD, Gregson B. Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000200. doi: 10.1002/14651858.CD000200.pub2.
  PMID: 18843607
  citation: Li Y, Yang R, Li Z, Yang Y, Tian B, Zhang X, Wang B, Lu D, Guo S, Man M, Yang Y, Luo T, Gao G, Li L. Surgical Evacuation of Spontaneous Supratentorial Lobar Intracerebral Hemorrhage: Comparison of Safety and Efficacy of Stereotactic Aspiration, Endoscopic Surgery, and Craniotomy. World Neurosurg. 2017 Sep;105:332-340. doi: 10.1016/j.wneu.2017.05.134. Epub 2017 May 31.
  PMID: 28578111
  citation: Yao Z, Ma L, You C, He M. Decompressive Craniectomy for Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis. World Neurosurg. 2018 Feb;110:121-128. doi: 10.1016/j.wneu.2017.10.167. Epub 2017 Nov 10.
  PMID: 29129764
  citation: Zheng J, Li H, Zhao HX, Guo R, Lin S, Dong W, Ma L, Fang Y, Tian M, Liu M, You C. Surgery for Patients With Spontaneous Deep Supratentorial Intracerebral Hemorrhage: A Retrospective Case-Control Study Using Propensity Score Matching. Medicine (Baltimore). 2016 Mar;95(11):e3024. doi: 10.1097/MD.0000000000003024.
  PMID: 26986116
  citation: Stein M, Misselwitz B, Hamann GF, Kolodziej M, Reinges MH, Uhl E. In-hospital mortality after pre-treatment with antiplatelet agents or oral anticoagulants and hematoma evacuation of intracerebral hematomas. J Clin Neurosci. 2016 Apr;26:42-5. doi: 10.1016/j.jocn.2015.05.069. Epub 2015 Dec 11.
  PMID: 26690758
  citation: Khoo KF, Lepas B. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Jan 7;82(1):95. doi: 10.1212/01.NEUROLOGY.0000437348.92583.18. No abstract available.
  PMID: 24379098
  citation: Holzmacher JL, Reynolds C, Patel M, Maluso P, Holland S, Gamsky N, Moore H, Acquista E, Carrick M, Amdur R, Hancock H, Metzler M, Dunn J, Sarani B. Platelet transfusion does not improve outcomes in patients with brain injury on antiplatelet therapy. Brain Inj. 2018;32(3):325-330. doi: 10.1080/02699052.2018.1425804. Epub 2018 Jan 17.
  PMID: 29341793
  citation: Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD; Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology. 2003 Sep;110(9):1784-8. doi: 10.1016/S0161-6420(03)00785-1. Erratum In: Ophthalmology. 2003 Dec;110(12):2309.
  PMID: 13129878
  responsible party type: Principal Investigator
  investigator affiliation: Beijing Tiantan Hospital
  investigator full name: Wang Shuo
  investigator title: Director of Department of Cerebrovascular Neurosurgery
  mesh term: Cerebral Hemorrhage
  mesh term: Intracranial Hemorrhages
  mesh term: Emergencies
  mesh term: Hemorrhage
  sharing ipd: No